Global Vaccine Packaging Market

Market Insights on the Vaccine Packaging Market, including sales forecast, demand outlook, and key trends

Vaccine Packaging Market- By Packaging Material, Packaging Type Vaccine Type, and End-User & Region - Forecast to 2023-2033

Category: Life Sciences Published Date : May-23 ID: CVC-51921 Format: PDF Pages: 265

Report Highlights According to a research survey conducted by ChemView Consulting, the Vaccine Packaging Market was worth US$ 1.5 Bn. The market is expected to grow at a CAGR of 13.20% between the 2023 and 2033 to reach US$ 5.1 Bn.



Report Includes

Research Scope/Taxonomy:

  • Market Analysis by Packaging Material:
    • Glass
    • Plastic
    • Metal
    • Others
  • Market Analysis by Packaging Type:
    • Vials
    • Ampoules
    • Syringes
    • Bottles
    • Cartridges
    • Others
  • Market Analysis by Vaccine Type:
    • COVID-19
    • Influenza
    • Measles, Mumps, and Rubella (MMR)
    • Hepatitis
    • Polio
    • Others
  • Market Analysis by End-User:
    • Pharmaceutical Companies
    • Hospitals & Clinics
    • Research Institutes
    • Others
  • Market Analysis by Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa






Analyst Credentials

Key Companies Profiled:

  • Schott AG
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • Becton, Dickinson and Company (BD)
  • Amcor plc
  • WestRock Company
  • SGD Pharma
  • SiO2 Materials Science
  • Catalent, Inc.
  • Stevanato Group
  • Bilcare Limited
  • Carcano Antonio S.p.A.
  • Conservatek Industries Inc.
  • DWK Life Sciences
  • First Priority Packaging
  • Phoenix Packaging Operations
  • Unilife Corporation
  • Comar, LLC
  • Corning Incorporated
  • SGI Architectural

1.1. Global Market Snapshot

1.2. Key Success Factors

1.3. Strategic Analysis and Recommendations

2.1. Market Taxonomy

2.2. Market Definitions

3.1. Preliminary Investigation & Research Design

3.2. Secondary Research & Primary Research

3.3. Data Analysis & Econometric Modelling

3.4. Expert Data Validation

4.1. Supply-Side Trends

4.2. Demand-Side Trends

5.1. Global Market Value (US$ Mn) Analysis, 2017 – 2032

5.2. Incremental $ Opportunity Index, 2022-2032

5.3. Global Market Volume (Tons) Analysis, 2017 – 2032

6.1. Regional Level Pricing Analysis and Forecast

6.1.1. Manufacturers Level Pricing

6.1.2. Distributor Level Pricing

6.2. Global Pricing Analysis Benchmark

6.3. Cost Breakdown Analysis

7.1. Cross Analysis of Packaging Type W.R.T. Packaging Material

8.1. Regional Supply Vs. Demand Gap Assessment

8.2. Top Producing Countries Analysis

9.1. Macroeconomic Factors

9.2. Forecast Factors

9.3. Market Dynamics

9.3.1. Driver

9.3.2. Restraint

9.3.3. Opportunity

9.4. Supply Chain Analysis

9.4.1. List Raw Material Suppliers

9.4.2. List of Manufacturers

9.4.3. List of Distributors

9.4.4. List of End-Users

9.4.5. End-Users Consumption Analysis

9.4.6. Average Profitability Margin Analysis

9.5. Covid-19 Impact Assessment

9.5.1. Economy/Cluster Projections

9.5.2. Covid-19 Economic Assessment

9.5.3. Impact on Target Market

9.5.4. Recovery Scenario

9.6. Regulatory Framework

9.6.1. Regulations of Key Countries

9.6.2. Potential Impact of Regulations

9.7. Porter’s Five Forces Analysis

9.8. Technology Landscape

10.1. Introduction

10.2. Key Market Trends

10.3. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Packaging Material [Value (US$ Mn) and Volume (Tons) Analysis]

10.3.1. Glass

10.3.2. Plastic

10.3.3. Metal

10.3.4. Others

10.4. Market Attractiveness Analysis by Packaging Material

11.1. Introduction

11.2. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Packaging Type [Value (US$ Mn) and Volume (Tons) Analysis]

11.2.1. Vials

11.2.2. Ampoules

11.2.3. Syringes

11.2.4. Bottles

11.2.5. Cartridges

11.2.6. Others

11.3. Market Attractiveness Analysis by Packaging Type

12.1. Introduction

12.2. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Vaccine Type [Value (US$ Mn) and Volume (Tons) Analysis]

12.2.1. COVID-19

12.2.2. Influenza

12.2.3. Measles, Mumps, and Rubella (MMR)

12.2.4. Hepatitis

12.2.5. Polio

12.2.6. Others

12.3. Market Attractiveness Analysis by Vaccine Type

13.1. Introduction

13.2. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By End User [Value (US$ Mn) and Volume (Tons) Analysis]

13.2.1. Pharmaceutical Companies

13.2.2. Hospitals & Clinics

13.2.3. Research Institutes

13.2.4. Others

13.3. Market Attractiveness Analysis by End User

14.1. Introduction

14.2. Key Market Trends

14.3. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Region [Value (US$ Mn) and Volume (Tons) Analysis]

14.3.1. North America

14.3.2. Latin America

14.3.3. Europe

14.3.4. Asia-Pacific

14.3.5. Middle East

14.3.6. Africa

14.4. Market Attractiveness Analysis by Region

15.1. Introduction

15.2. Key Market Trends

15.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

15.3.1. By Country

15.3.1.1. U.S.

15.3.1.2. Canada

15.3.2. By Packaging Material

15.3.3. By Packaging Type

15.3.4. By Vaccine Type

15.3.5. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Packaging Material

15.4.3. By Packaging Type

15.4.4. By Vaccine Type

15.4.5. By End User

16.1. Introduction

16.2. Key Market Trends

16.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

16.3.1. By Country

16.3.1.1. Brazil

16.3.1.2. Mexico

16.3.1.3. Rest of Latin America

16.3.2. By Packaging Material

16.3.3. By Packaging Type

16.3.4. By Vaccine Type

16.3.5. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Packaging Material

16.4.3. By Packaging Type

16.4.4. By Vaccine Type

16.4.5. By End User

17.1. Introduction

17.2. Key Market Trends

17.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

17.3.1. By Country

17.3.1.1. Germany

17.3.1.2. Italy

17.3.1.3. France

17.3.1.4. UK

17.3.1.5. Spain

17.3.1.6. Netherlands

17.3.1.7. Norway

17.3.1.8. Russia

17.3.1.9. Rest of Europe

17.3.2. By Packaging Material

17.3.3. By Packaging Type

17.3.4. By Vaccine Type

17.3.5. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Packaging Material

17.4.3. By Packaging Type

17.4.4. By Vaccine Type

17.4.5. By End User

18.1. Introduction

18.2. Key Market Trends

18.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

18.3.1. By Country

18.3.1.1. China

18.3.1.2. Japan

18.3.1.3. South Korea

18.3.1.4. India

18.3.1.5. Indonesia

18.3.1.6. Thailand

18.3.1.7. Vietnam

18.3.1.8. Australia & New Zealand

18.3.1.9. Rest of Asia-Pacific

18.3.2. By Packaging Material

18.3.3. By Packaging Type

18.3.4. By Vaccine Type

18.3.5. By End User

18.4. Market Attractiveness Analysis

18.4.1. By Country

18.4.2. By Packaging Material

18.4.3. By Packaging Type

18.4.4. By Vaccine Type

18.4.5. By End User

19.1. Introduction

19.2. Key Market Trends

19.3. Pricing Analysis

19.4. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

19.4.1. By Country

19.4.1.1. Saudi Arabia

19.4.1.2. Turkey

19.4.1.3. U.A.E.

19.4.1.4. Rest of the Middle East

19.4.2. By Packaging Material

19.4.3. By Packaging Type

19.4.4. By Vaccine Type

19.4.5. By End User

19.5. Market Attractiveness Analysis

19.5.1. By Country

19.5.2. By Packaging Material

19.5.3. By Packaging Type

19.5.4. By Vaccine Type

19.5.5. By End User

20.1. Introduction

20.2. Key Market Trends

20.3. Pricing Analysis

20.4. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

20.4.1. By Country

20.4.1.1. South Africa

20.4.1.2. Nigeria

20.4.1.3. Egypt

20.4.1.4. Rest of Africa

20.4.2. By Packaging Material

20.4.3. By Packaging Type

20.4.4. By Vaccine Type

20.4.5. By End User

20.5. Market Attractiveness Analysis

20.5.1. By Country

20.5.2. By Packaging Material

20.5.3. By Packaging Type

20.5.4. By Vaccine Type

20.5.5. By End User

21.1. Tier Structure Breakdown

21.2. Market Share Analysis

21.3. Production Capacity Analysis

21.4. Company Footprint Analysis

21.4.1. Product Footprint of Players

21.4.2. Regional Footprint of Players

21.4.3. Channel Footprint of Players

21.5. Brand Preference Analysis

21.6. Competition Dashboard

22.1. Schott AG.

22.1.1. Company Overview

22.1.2. Product & Financial Portfolio

22.1.3. Manufacturing Facilities

22.1.4. Recent Developments

22.1.5. SWOT Analysis

22.1.6. Strategy Overview

22.2. Gerresheimer AG

22.3. West Pharmaceutical Services, Inc.

22.4. Becton, Dickinson and Company (BD)

22.5. Amcor plc

22.6. WestRock Company

22.7. SGD Pharma

22.8. SiO2 Materials Science

22.9. Catalent, Inc.

22.10. Stevanato Group

22.11. Bilcare Limited

22.12. Carcano Antonio S.p.A.

22.13. Conservatek Industries Inc.

22.14. DWK Life Sciences

22.15. First Priority Packaging

22.16. Phoenix Packaging Operations

22.17. Unilife Corporation

22.18. Comar, LLC

22.19. Corning Incorporated

22.20. SGI Architectural